Columnist Oluwatosin Adesoye shares some of the most harrowing sickle cell crises she's endured throughout her life.

Higher levels of fetal hemoglobin may guard against lung problems and delay bone damage in people with sickle cell disease, ...

Columnist Michelle Harlan has set some health goals for the new year, and to her delight, they're not that different from ...

Emmaus Life Sciences has entered into an agreement to sell the North American rights to its oral sickle cell disease ...

Self-advocacy skills help to build confidence and reduce feelings of helplessness, writes columnist. It's good to start young ...

SCD gene therapy approaches using CRISPR, gene therapy, and base editing show different stem cell outcomes in a mouse study.

The year began with travel, first to the United States, and then to Mexico. Experiencing new cultures and cuisines brought me immense joy. Over the years, I’ve become a true foodie; discovering new ...

Although approximately 1 in 6 people worldwide are living with a significant disability, the narrative that those of us with disabilities deserve less continues to be perpetuated. Though frustrating, ...

Note: This story was updated Dec. 12, 2023, to clarify that Lyfgenia treats vaso-occlusive events, including painful vaso-occlusive crises (VOCs). The U.S. Food and Drug Administration (FDA) has ...

The Centers for Medicare & Medicaid Services (CMS) has announced that 33 states, along with the District of Columbia and Puerto Rico, have agreed to participate in the Cell and Gene Therapy (CGT) ...

Children’s Hospital Los Angeles (CHLA) is now offering Casgevy (exagamglogene autotemcel), an approved gene-editing therapy for sickle cell disease (SCD). “This is a transformative time for Children’s ...